nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Ototoxicity—Docetaxel—melanoma	0.0277	0.0277	CcSEcCtD
Vancomycin—Nephrotoxicity—Carmustine—melanoma	0.0272	0.0272	CcSEcCtD
Vancomycin—Rigors—Vemurafenib—melanoma	0.02	0.02	CcSEcCtD
Vancomycin—Nephropathy toxic—Bleomycin—melanoma	0.0172	0.0172	CcSEcCtD
Vancomycin—Vasculitis—Vemurafenib—melanoma	0.0167	0.0167	CcSEcCtD
Vancomycin—Drug fever—Docetaxel—melanoma	0.0166	0.0166	CcSEcCtD
Vancomycin—Azotaemia—Carmustine—melanoma	0.0162	0.0162	CcSEcCtD
Vancomycin—Nephropathy toxic—Carmustine—melanoma	0.015	0.015	CcSEcCtD
Vancomycin—Necrosis—Dactinomycin—melanoma	0.0118	0.0118	CcSEcCtD
Vancomycin—Tenderness—Bleomycin—melanoma	0.0113	0.0113	CcSEcCtD
Vancomycin—Extravasation—Bleomycin—melanoma	0.0113	0.0113	CcSEcCtD
Vancomycin—Necrosis—Carmustine—melanoma	0.011	0.011	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.0107	0.0107	CcSEcCtD
Vancomycin—Extravasation—Dactinomycin—melanoma	0.0106	0.0106	CcSEcCtD
Vancomycin—Rigors—Temozolomide—melanoma	0.0102	0.0102	CcSEcCtD
Vancomycin—Eosinophilia—Vemurafenib—melanoma	0.0101	0.0101	CcSEcCtD
Vancomycin—Extravasation—Carmustine—melanoma	0.0099	0.0099	CcSEcCtD
Vancomycin—Wheezing—Bleomycin—melanoma	0.00961	0.00961	CcSEcCtD
Vancomycin—Infestation NOS—Vemurafenib—melanoma	0.00914	0.00914	CcSEcCtD
Vancomycin—Infestation—Vemurafenib—melanoma	0.00914	0.00914	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00906	0.00906	CcSEcCtD
Vancomycin—Hearing impaired—Temozolomide—melanoma	0.00877	0.00877	CcSEcCtD
Vancomycin—Phlebitis—Bleomycin—melanoma	0.00834	0.00834	CcSEcCtD
Vancomycin—Oedema peripheral—Vemurafenib—melanoma	0.00808	0.00808	CcSEcCtD
Vancomycin—Connective tissue disorder—Vemurafenib—melanoma	0.00806	0.00806	CcSEcCtD
Vancomycin—Phlebitis—Dactinomycin—melanoma	0.00778	0.00778	CcSEcCtD
Vancomycin—Erythema multiforme—Vemurafenib—melanoma	0.00776	0.00776	CcSEcCtD
Vancomycin—Chills—Vemurafenib—melanoma	0.00736	0.00736	CcSEcCtD
Vancomycin—Phlebitis—Carmustine—melanoma	0.00728	0.00728	CcSEcCtD
Vancomycin—Thrombophlebitis—Carmustine—melanoma	0.00724	0.00724	CcSEcCtD
Vancomycin—Erythema—Vemurafenib—melanoma	0.00714	0.00714	CcSEcCtD
Vancomycin—Malnutrition—Vemurafenib—melanoma	0.00714	0.00714	CcSEcCtD
Vancomycin—Necrosis—Docetaxel—melanoma	0.00707	0.00707	CcSEcCtD
Vancomycin—Thrombophlebitis—Temozolomide—melanoma	0.007	0.007	CcSEcCtD
Vancomycin—Back pain—Vemurafenib—melanoma	0.00691	0.00691	CcSEcCtD
Vancomycin—Rigors—Docetaxel—melanoma	0.0068	0.0068	CcSEcCtD
Vancomycin—Deafness—Temozolomide—melanoma	0.00677	0.00677	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Temozolomide—melanoma	0.00642	0.00642	CcSEcCtD
Vancomycin—Extravasation—Docetaxel—melanoma	0.00636	0.00636	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00604	0.00604	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00603	0.00603	CcSEcCtD
Vancomycin—Hearing impaired—Docetaxel—melanoma	0.00583	0.00583	CcSEcCtD
Vancomycin—Anaphylactic shock—Vemurafenib—melanoma	0.00583	0.00583	CcSEcCtD
Vancomycin—Infection—Vemurafenib—melanoma	0.00579	0.00579	CcSEcCtD
Vancomycin—Nervous system disorder—Vemurafenib—melanoma	0.00571	0.00571	CcSEcCtD
Vancomycin—Hypokalaemia—Carmustine—melanoma	0.00571	0.00571	CcSEcCtD
Vancomycin—Skin disorder—Vemurafenib—melanoma	0.00566	0.00566	CcSEcCtD
Vancomycin—Hypokalaemia—Temozolomide—melanoma	0.00551	0.00551	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00546	0.00546	CcSEcCtD
Vancomycin—Hypotension—Vemurafenib—melanoma	0.00545	0.00545	CcSEcCtD
Vancomycin—Neutropenia—Dactinomycin—melanoma	0.00541	0.00541	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00512	0.00512	CcSEcCtD
Vancomycin—Neutropenia—Carmustine—melanoma	0.00507	0.00507	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00503	0.00503	CcSEcCtD
Vancomycin—Fatigue—Vemurafenib—melanoma	0.00502	0.00502	CcSEcCtD
Vancomycin—Constipation—Vemurafenib—melanoma	0.00498	0.00498	CcSEcCtD
Vancomycin—Neutropenia—Temozolomide—melanoma	0.0049	0.0049	CcSEcCtD
Vancomycin—Agranulocytosis—Dactinomycin—melanoma	0.00482	0.00482	CcSEcCtD
Vancomycin—Renal failure—Carmustine—melanoma	0.00475	0.00475	CcSEcCtD
Vancomycin—Urinary tract infection—Carmustine—melanoma	0.0047	0.0047	CcSEcCtD
Vancomycin—Phlebitis—Docetaxel—melanoma	0.00468	0.00468	CcSEcCtD
Vancomycin—Infestation NOS—Temozolomide—melanoma	0.00467	0.00467	CcSEcCtD
Vancomycin—Infestation—Temozolomide—melanoma	0.00467	0.00467	CcSEcCtD
Vancomycin—Thrombophlebitis—Docetaxel—melanoma	0.00465	0.00465	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00463	0.00463	CcSEcCtD
Vancomycin—Flushing—Bleomycin—melanoma	0.00461	0.00461	CcSEcCtD
Vancomycin—Body temperature increased—Vemurafenib—melanoma	0.00461	0.00461	CcSEcCtD
Vancomycin—Urinary tract infection—Temozolomide—melanoma	0.00454	0.00454	CcSEcCtD
Vancomycin—Deafness—Docetaxel—melanoma	0.0045	0.0045	CcSEcCtD
Vancomycin—Chills—Bleomycin—melanoma	0.00446	0.00446	CcSEcCtD
Vancomycin—Erythema multiforme—Dactinomycin—melanoma	0.00438	0.00438	CcSEcCtD
Vancomycin—Erythema—Bleomycin—melanoma	0.00433	0.00433	CcSEcCtD
Vancomycin—Flushing—Dactinomycin—melanoma	0.0043	0.0043	CcSEcCtD
Vancomycin—Hypersensitivity—Vemurafenib—melanoma	0.00429	0.00429	CcSEcCtD
Vancomycin—Oedema peripheral—Carmustine—melanoma	0.00427	0.00427	CcSEcCtD
Vancomycin—Connective tissue disorder—Carmustine—melanoma	0.00426	0.00426	CcSEcCtD
Vancomycin—Renal impairment—Docetaxel—melanoma	0.00423	0.00423	CcSEcCtD
Vancomycin—Dermatitis bullous—Docetaxel—melanoma	0.00422	0.00422	CcSEcCtD
Vancomycin—Asthenia—Vemurafenib—melanoma	0.00418	0.00418	CcSEcCtD
Vancomycin—Chills—Dactinomycin—melanoma	0.00416	0.00416	CcSEcCtD
Vancomycin—Oedema peripheral—Temozolomide—melanoma	0.00413	0.00413	CcSEcCtD
Vancomycin—Pruritus—Vemurafenib—melanoma	0.00412	0.00412	CcSEcCtD
Vancomycin—Connective tissue disorder—Temozolomide—melanoma	0.00412	0.00412	CcSEcCtD
Vancomycin—Erythema—Dactinomycin—melanoma	0.00403	0.00403	CcSEcCtD
Vancomycin—Flushing—Carmustine—melanoma	0.00403	0.00403	CcSEcCtD
Vancomycin—Anaemia—Bleomycin—melanoma	0.004	0.004	CcSEcCtD
Vancomycin—Erythema multiforme—Temozolomide—melanoma	0.00396	0.00396	CcSEcCtD
Vancomycin—Tinnitus—Temozolomide—melanoma	0.00391	0.00391	CcSEcCtD
Vancomycin—Flushing—Temozolomide—melanoma	0.00389	0.00389	CcSEcCtD
Vancomycin—Dizziness—Vemurafenib—melanoma	0.00385	0.00385	CcSEcCtD
Vancomycin—Malnutrition—Carmustine—melanoma	0.00378	0.00378	CcSEcCtD
Vancomycin—Erythema—Carmustine—melanoma	0.00378	0.00378	CcSEcCtD
Vancomycin—Chills—Temozolomide—melanoma	0.00376	0.00376	CcSEcCtD
Vancomycin—Anaemia—Dactinomycin—melanoma	0.00373	0.00373	CcSEcCtD
Vancomycin—Vomiting—Vemurafenib—melanoma	0.00371	0.00371	CcSEcCtD
Vancomycin—Rash—Vemurafenib—melanoma	0.00367	0.00367	CcSEcCtD
Vancomycin—Dermatitis—Vemurafenib—melanoma	0.00367	0.00367	CcSEcCtD
Vancomycin—Back pain—Carmustine—melanoma	0.00365	0.00365	CcSEcCtD
Vancomycin—Headache—Vemurafenib—melanoma	0.00365	0.00365	CcSEcCtD
Vancomycin—Erythema—Temozolomide—melanoma	0.00365	0.00365	CcSEcCtD
Vancomycin—Malnutrition—Temozolomide—melanoma	0.00365	0.00365	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00363	0.00363	CcSEcCtD
Vancomycin—Anaphylactic shock—Bleomycin—melanoma	0.00353	0.00353	CcSEcCtD
Vancomycin—Back pain—Temozolomide—melanoma	0.00353	0.00353	CcSEcCtD
Vancomycin—Infection—Bleomycin—melanoma	0.00351	0.00351	CcSEcCtD
Vancomycin—Anaemia—Carmustine—melanoma	0.00349	0.00349	CcSEcCtD
Vancomycin—Nausea—Vemurafenib—melanoma	0.00346	0.00346	CcSEcCtD
Vancomycin—Thrombocytopenia—Bleomycin—melanoma	0.00346	0.00346	CcSEcCtD
Vancomycin—Anaemia—Temozolomide—melanoma	0.00337	0.00337	CcSEcCtD
Vancomycin—Hypotension—Bleomycin—melanoma	0.0033	0.0033	CcSEcCtD
Vancomycin—Vertigo—Temozolomide—melanoma	0.00328	0.00328	CcSEcCtD
Vancomycin—Infection—Dactinomycin—melanoma	0.00327	0.00327	CcSEcCtD
Vancomycin—Neutropenia—Docetaxel—melanoma	0.00326	0.00326	CcSEcCtD
Vancomycin—Palpitations—Temozolomide—melanoma	0.00322	0.00322	CcSEcCtD
Vancomycin—Thrombocytopenia—Dactinomycin—melanoma	0.00322	0.00322	CcSEcCtD
Vancomycin—Dyspnoea—Bleomycin—melanoma	0.00315	0.00315	CcSEcCtD
Vancomycin—Infestation NOS—Docetaxel—melanoma	0.00311	0.00311	CcSEcCtD
Vancomycin—Infestation—Docetaxel—melanoma	0.00311	0.00311	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00309	0.00309	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00308	0.00308	CcSEcCtD
Vancomycin—Infection—Carmustine—melanoma	0.00306	0.00306	CcSEcCtD
Vancomycin—Renal failure—Docetaxel—melanoma	0.00305	0.00305	CcSEcCtD
Vancomycin—Pain—Bleomycin—melanoma	0.00302	0.00302	CcSEcCtD
Vancomycin—Thrombocytopenia—Carmustine—melanoma	0.00302	0.00302	CcSEcCtD
Vancomycin—Tachycardia—Carmustine—melanoma	0.00301	0.00301	CcSEcCtD
Vancomycin—Anaphylactic shock—Temozolomide—melanoma	0.00298	0.00298	CcSEcCtD
Vancomycin—Infection—Temozolomide—melanoma	0.00296	0.00296	CcSEcCtD
Vancomycin—Nervous system disorder—Temozolomide—melanoma	0.00292	0.00292	CcSEcCtD
Vancomycin—Thrombocytopenia—Temozolomide—melanoma	0.00292	0.00292	CcSEcCtD
Vancomycin—Agranulocytosis—Docetaxel—melanoma	0.0029	0.0029	CcSEcCtD
Vancomycin—Skin disorder—Temozolomide—melanoma	0.00289	0.00289	CcSEcCtD
Vancomycin—Hypotension—Carmustine—melanoma	0.00288	0.00288	CcSEcCtD
Vancomycin—Fatigue—Dactinomycin—melanoma	0.00284	0.00284	CcSEcCtD
Vancomycin—Pain—Dactinomycin—melanoma	0.00282	0.00282	CcSEcCtD
Vancomycin—Urticaria—Bleomycin—melanoma	0.0028	0.0028	CcSEcCtD
Vancomycin—Body temperature increased—Bleomycin—melanoma	0.00279	0.00279	CcSEcCtD
Vancomycin—Insomnia—Carmustine—melanoma	0.00279	0.00279	CcSEcCtD
Vancomycin—Dyspnoea—Carmustine—melanoma	0.00275	0.00275	CcSEcCtD
Vancomycin—Oedema peripheral—Docetaxel—melanoma	0.00275	0.00275	CcSEcCtD
Vancomycin—Connective tissue disorder—Docetaxel—melanoma	0.00274	0.00274	CcSEcCtD
Vancomycin—Insomnia—Temozolomide—melanoma	0.00269	0.00269	CcSEcCtD
Vancomycin—Gastrointestinal pain—Dactinomycin—melanoma	0.00269	0.00269	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Carmustine—melanoma	0.00266	0.00266	CcSEcCtD
Vancomycin—Dyspnoea—Temozolomide—melanoma	0.00266	0.00266	CcSEcCtD
Vancomycin—Erythema multiforme—Docetaxel—melanoma	0.00264	0.00264	CcSEcCtD
Vancomycin—Pain—Carmustine—melanoma	0.00264	0.00264	CcSEcCtD
Vancomycin—Constipation—Carmustine—melanoma	0.00264	0.00264	CcSEcCtD
Vancomycin—Abdominal pain—Dactinomycin—melanoma	0.0026	0.0026	CcSEcCtD
Vancomycin—Body temperature increased—Dactinomycin—melanoma	0.0026	0.0026	CcSEcCtD
Vancomycin—Hypersensitivity—Bleomycin—melanoma	0.0026	0.0026	CcSEcCtD
Vancomycin—Flushing—Docetaxel—melanoma	0.00259	0.00259	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Temozolomide—melanoma	0.00257	0.00257	CcSEcCtD
Vancomycin—Fatigue—Temozolomide—melanoma	0.00257	0.00257	CcSEcCtD
Vancomycin—Pain—Temozolomide—melanoma	0.00255	0.00255	CcSEcCtD
Vancomycin—Constipation—Temozolomide—melanoma	0.00255	0.00255	CcSEcCtD
Vancomycin—Asthenia—Bleomycin—melanoma	0.00253	0.00253	CcSEcCtD
Vancomycin—Gastrointestinal pain—Carmustine—melanoma	0.00252	0.00252	CcSEcCtD
Vancomycin—Chills—Docetaxel—melanoma	0.0025	0.0025	CcSEcCtD
Vancomycin—Pruritus—Bleomycin—melanoma	0.0025	0.0025	CcSEcCtD
Vancomycin—Body temperature increased—Carmustine—melanoma	0.00244	0.00244	CcSEcCtD
Vancomycin—Abdominal pain—Carmustine—melanoma	0.00244	0.00244	CcSEcCtD
Vancomycin—Gastrointestinal pain—Temozolomide—melanoma	0.00244	0.00244	CcSEcCtD
Vancomycin—Erythema—Docetaxel—melanoma	0.00243	0.00243	CcSEcCtD
Vancomycin—Malnutrition—Docetaxel—melanoma	0.00243	0.00243	CcSEcCtD
Vancomycin—Hypersensitivity—Dactinomycin—melanoma	0.00243	0.00243	CcSEcCtD
Vancomycin—Urticaria—Temozolomide—melanoma	0.00237	0.00237	CcSEcCtD
Vancomycin—Asthenia—Dactinomycin—melanoma	0.00236	0.00236	CcSEcCtD
Vancomycin—Abdominal pain—Temozolomide—melanoma	0.00235	0.00235	CcSEcCtD
Vancomycin—Body temperature increased—Temozolomide—melanoma	0.00235	0.00235	CcSEcCtD
Vancomycin—Back pain—Docetaxel—melanoma	0.00235	0.00235	CcSEcCtD
Vancomycin—Muscle spasms—Docetaxel—melanoma	0.00233	0.00233	CcSEcCtD
Vancomycin—Hypersensitivity—Carmustine—melanoma	0.00227	0.00227	CcSEcCtD
Vancomycin—Vomiting—Bleomycin—melanoma	0.00224	0.00224	CcSEcCtD
Vancomycin—Anaemia—Docetaxel—melanoma	0.00224	0.00224	CcSEcCtD
Vancomycin—Rash—Bleomycin—melanoma	0.00223	0.00223	CcSEcCtD
Vancomycin—Dermatitis—Bleomycin—melanoma	0.00222	0.00222	CcSEcCtD
Vancomycin—Asthenia—Carmustine—melanoma	0.00221	0.00221	CcSEcCtD
Vancomycin—Hypersensitivity—Temozolomide—melanoma	0.00219	0.00219	CcSEcCtD
Vancomycin—Palpitations—Docetaxel—melanoma	0.00214	0.00214	CcSEcCtD
Vancomycin—Asthenia—Temozolomide—melanoma	0.00214	0.00214	CcSEcCtD
Vancomycin—Pruritus—Temozolomide—melanoma	0.00211	0.00211	CcSEcCtD
Vancomycin—Nausea—Bleomycin—melanoma	0.0021	0.0021	CcSEcCtD
Vancomycin—Vomiting—Dactinomycin—melanoma	0.00209	0.00209	CcSEcCtD
Vancomycin—Rash—Dactinomycin—melanoma	0.00208	0.00208	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00205	0.00205	CcSEcCtD
Vancomycin—Dizziness—Carmustine—melanoma	0.00204	0.00204	CcSEcCtD
Vancomycin—Anaphylactic shock—Docetaxel—melanoma	0.00198	0.00198	CcSEcCtD
Vancomycin—Dizziness—Temozolomide—melanoma	0.00197	0.00197	CcSEcCtD
Vancomycin—Infection—Docetaxel—melanoma	0.00197	0.00197	CcSEcCtD
Vancomycin—Vomiting—Carmustine—melanoma	0.00196	0.00196	CcSEcCtD
Vancomycin—Nausea—Dactinomycin—melanoma	0.00196	0.00196	CcSEcCtD
Vancomycin—Rash—Carmustine—melanoma	0.00194	0.00194	CcSEcCtD
Vancomycin—Nervous system disorder—Docetaxel—melanoma	0.00194	0.00194	CcSEcCtD
Vancomycin—Dermatitis—Carmustine—melanoma	0.00194	0.00194	CcSEcCtD
Vancomycin—Thrombocytopenia—Docetaxel—melanoma	0.00194	0.00194	CcSEcCtD
Vancomycin—Tachycardia—Docetaxel—melanoma	0.00193	0.00193	CcSEcCtD
Vancomycin—Headache—Carmustine—melanoma	0.00193	0.00193	CcSEcCtD
Vancomycin—Skin disorder—Docetaxel—melanoma	0.00192	0.00192	CcSEcCtD
Vancomycin—Vomiting—Temozolomide—melanoma	0.00189	0.00189	CcSEcCtD
Vancomycin—Rash—Temozolomide—melanoma	0.00188	0.00188	CcSEcCtD
Vancomycin—Dermatitis—Temozolomide—melanoma	0.00188	0.00188	CcSEcCtD
Vancomycin—Headache—Temozolomide—melanoma	0.00187	0.00187	CcSEcCtD
Vancomycin—Hypotension—Docetaxel—melanoma	0.00185	0.00185	CcSEcCtD
Vancomycin—Nausea—Carmustine—melanoma	0.00183	0.00183	CcSEcCtD
Vancomycin—Insomnia—Docetaxel—melanoma	0.00179	0.00179	CcSEcCtD
Vancomycin—Nausea—Temozolomide—melanoma	0.00177	0.00177	CcSEcCtD
Vancomycin—Dyspnoea—Docetaxel—melanoma	0.00177	0.00177	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Docetaxel—melanoma	0.00171	0.00171	CcSEcCtD
Vancomycin—Fatigue—Docetaxel—melanoma	0.00171	0.00171	CcSEcCtD
Vancomycin—Pain—Docetaxel—melanoma	0.00169	0.00169	CcSEcCtD
Vancomycin—Constipation—Docetaxel—melanoma	0.00169	0.00169	CcSEcCtD
Vancomycin—Gastrointestinal pain—Docetaxel—melanoma	0.00162	0.00162	CcSEcCtD
Vancomycin—Body temperature increased—Docetaxel—melanoma	0.00157	0.00157	CcSEcCtD
Vancomycin—Abdominal pain—Docetaxel—melanoma	0.00157	0.00157	CcSEcCtD
Vancomycin—Hypersensitivity—Docetaxel—melanoma	0.00146	0.00146	CcSEcCtD
Vancomycin—Asthenia—Docetaxel—melanoma	0.00142	0.00142	CcSEcCtD
Vancomycin—Pruritus—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Vancomycin—Dizziness—Docetaxel—melanoma	0.00131	0.00131	CcSEcCtD
Vancomycin—Vomiting—Docetaxel—melanoma	0.00126	0.00126	CcSEcCtD
Vancomycin—Rash—Docetaxel—melanoma	0.00125	0.00125	CcSEcCtD
Vancomycin—Dermatitis—Docetaxel—melanoma	0.00125	0.00125	CcSEcCtD
Vancomycin—Headache—Docetaxel—melanoma	0.00124	0.00124	CcSEcCtD
Vancomycin—Nausea—Docetaxel—melanoma	0.00118	0.00118	CcSEcCtD
